Day: December 4, 2024

BIZENGRI® is the first and only therapy approved by the FDA specifically for pancreatic adenocarcinoma and NSCLC that harbor NRG1 gene fusions and are advanced unresectable or metastatic1 Merus and Partner Therapeutics announced a license agreement for U.S. commercializationUTRECHT, The Netherlands and CAMBRIDGE, Mass., Dec. 04, 2024 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS) [Merus, the Company, we, or our], a clinical-stage oncology company developing innovative, full-length, multispecific antibodies (Biclonics® and Triclonics®), announced today that the U.S. Food and Drug Administration (FDA) approved BIZENGRI® (zenocutuzumab-zbco), the first and only treatment indicated for adults with pancreatic adenocarcinoma or non–small cell lung cancer (NSCLC) that are advanced unresectable or metastatic and harbor a neuregulin 1...

MIDLAND, Pa., Dec. 04, 2024 (GLOBE NEWSWIRE) — Mawson Infrastructure Group, Inc. (NASDAQ: MIGI) (“Mawson” or “the Company”), a publicly-traded technology company focused on digital infrastructure platforms for artificial intelligence (AI), high-performance computing (HPC), and digital assets markets, notes that a media outlet earlier today falsely reported that the Company has filed a voluntary Chapter 11 petition. Rather, entities in Australia, including W Capital Advisors Pty Ltd as trustee for the W Capital Advisors Fund and Marshall Investments MIG Pty Ltd as trustee for the Marshall Investments MIG Trust, have filed an involuntary Chapter 11 petition against the Company. The Company has not yet been formally served with an involuntary petition; however, if served, the Company’s Board of Directors intend to vigorously defend...

AUSTIN, Texas, Dec. 04, 2024 (GLOBE NEWSWIRE) — FTC Solar, Inc. (Nasdaq: FTCI), a leading provider of solar tracker systems, today announced that it has closed a previously announced private placement of senior secured promissory notes (the “Notes”) in an aggregate principal amount of fifteen million dollars ($15,000,000) and warrants (the “Warrants”). The offering closed on December 4, 2024. The Notes bear interest at a rate of 11% per annum if payable in cash or, at the Company’s option, 13% per annum if paid-in-kind and will mature on December 4, 2029. The Warrants are exercisable for five (5) years to purchase an aggregate of 1,750,000 shares of Common Stock at an exercise price of $0.10, subject to adjustment under certain circumstances described in the Warrants. The Company is utilizing the proceeds of the offering for balance...

IDT’s income from operations +38% to $23.6 million; Adjusted EBITDA* +31% to a record $29.1 million GAAP EPS increased to $0.68 from $0.30; Non-GAAP EPS* increased to $0.71 from $0.32 NEWARK, NJ, Dec. 04, 2024 (GLOBE NEWSWIRE) — IDT Corporation (NYSE: IDT), a global provider of fintech, cloud communications, and traditional communications solutions, today reported results for its first quarter fiscal year 2025, the three months ended October 31, 2024. FIRST QUARTER HIGHLIGHTS (Throughout this release, unless otherwise noted, results for the first quarter of fiscal year 2025 (1Q25) are compared to the first quarter of fiscal year 2024 (1Q24). All earnings per share (EPS) and other ‘per share’ results are per diluted share.)Key Businesses / SegmentsNRSRecurring revenue**: +29% to $28.9 million; Income from operations: +21%...

HOUSTON, Dec. 04, 2024 (GLOBE NEWSWIRE) — Carriage Services, Inc. (NYSE: CSV) (“Carriage” or the “Company”) is excited to announce the appointment of John Enwright as Senior Vice President, Chief Financial Officer and Treasurer, effective January 2, 2025. With more than 25 years of extensive financial leadership experience in omnichannel retail, Mr. Enwright brings a proven track record of driving results and fostering innovation at prominent publicly traded companies. Most recently, he served as Chief Financial Officer for Edible Brands, LLC, following a successful eight-year tenure at Vera Bradley, Inc., where he spent five years as Chief Financial Officer, following several years as Vice President of Financial Planning and Analysis. His earlier career at Tiffany & Company, where he spent 15 years, equipped him with invaluable...